Cardiac Science Reports Q2 Revenue; Resumes AED...((1330) (749) ...),Health

Date:8/10/2009

(1,330) (749) Prepaid expenses and other assets 36 (624) Accounts payable (2,457) (236) Accrued liabilities (291) (384) Warranty liability 9 338 Deferred revenue (670) (490) ---- ---- Net cash provided by operating activities 4,226 8,794 ----- ----- Investing Activities: Maturities of short-term investments - 350 Purchases of machinery and equipment (1,654) (1,442) Proceeds from repayment of note 83 - Cash paid for acquisitions (54) (424) --- ---- Net cash used in investing activities (1,625) (1,516) ------ ------ Financing Activities: Proceeds from exercise of stock options and issuance of shares under employee stock purchase plan 736 346 Minimum tax withholding on restricted stock awards (97) (62) --- --- Net cash provided by financing
'/>"/>

SOURCE Cardiac Science Corporation Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Related medicine news :

1. Electronic Health Records Help Cardiac Patients Remain Healthy
2. Cooling treatment after cardiac arrest is cost-effective, Penn study shows
3. Harrison City ROCKS! Set for August 15, Music Festival to Benefit Cardiac Research at Childrens Hospital of Pittsburgh
4. Patriot Scientific Corporation Announces Cardiac Science Corporations Purchase of a Moore Microprocessor Patent(TM) Portfolio License
5. Many Heart Attack Patients Not Referred to Cardiac Rehab
6. Worlds First Cardiac Adult Stem Cell Patient and Physicians Discuss Clinical Trial
7. Roche Cardiac 200 Offers Rapid Cardiac Diagnostics for the Point of Care
8. Need for At-Home Blood Pressure Monitoring Underscored by High-Profile Cardiac Deaths
9. Cardiac CT is more cost effective when managing low-risk patients with chest pain
10. Improving Care for Cardiac Patients is Centerpiece of American Society of Nuclear Cardiology Meeting
11. ERT Launches New Online Gateway to Improve Cardiac Safety in Clinical Trials